Famotidine

DB00927ApprovedInvestigationalSmall moleculeHistamine H2 Antagonists

Famotidine is a histamine H2 receptor antagonist used to treat duodenal ulcers, benign gastric ulcers, GERD, and Zollinger-Ellison syndrome. Famotidine is a competitive histamine-2 (H2) receptor antagonist that works to inhibit gastric acid secretion.

Chemical structure of Famotidine
Mechanism
Curator reviewed · 2 references
Primary indication
Famotidine is indicated in pediatric and adult patients (with the bodyweight of 40 kg and above) for the management of active duodenal ulcer (DU), active gastric ulcer, symptomatic non-erosive gastroesophageal reflux disease (GERD), and erosive...Curator reviewed · 21 structured indications
Formula / weight
C8H15N7O2S3 · 337.445 g/mol (avg)
First approval
Canada, 1997 · United States, 1986
Code names
L 643341 · MK-208 · YM-11170
Brand names
  • Duo Fusion
  • Fluxid
  • Good Sense Acid Reducer
  • Pepcid
  • Pepcid Complete
  • Zantac Reformulated Aug 2022

Resolves to

Structure
InChIKeyXUFQPHANEAPEMJ-UHFFFAOYSA-NSMILESNC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1
Targets

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
4TransportersSubstrate / inhibitor direction, not just membership
Listed above
1,109Drug interactionsStructured to mechanism, not free text
Sign in
113Clinical trialsPhase, status and sponsor resolved per trial
Sign in
21Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
1ContraindicationEach with its own population and attribute set
Sign in
1,202Marketed productsAcross 11 countries and 368 labellers
Sign in
2ATC codesIncluding every combination product, plus 25 drug categories
Sign in
30+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Famotidine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account